Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Valproic Acid × CNS × Clear all

Phase

Phase 1 7 Phase 2 3 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 CNS 1

Conditions

Interventions

Saline Solution 5 Dexmedetomidine 5 Sodium Chloride 4 Levetiracetam 3 trametinib 2 perampanel 2 dabrafenib 2 Sugammadex 2 Sevoflurane 2 Propofol 2 Magnetic Resonance Spectroscopy 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Gentamicins 2 Fluorescein 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 pegvisomant 1 naxitamab 1 gadoterate meglumine 1 gadobenic acid 1 dexketoprofen trometamol 1 clevidipine 1 Vincristine 1 Valproic Acid 1 Trastuzumab 1 Tranexamic Acid 1 Tramadol 1 Thiotepa 1 Temozolomide 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡